Yi Li

Part of Shanghai Bioveda Investment Management Consulting Co. Ltd., BVCF Investment Consulting (Shanghai) Ltd. is a healthcare investment company based in Shanghai, China. BVCF actively assists business owners and entrepreneurs to build their companies into world-class businesses. The Chinese company has raised five funds and invests in growth-stage healthcare companies from around the world, with a particular focus on innovative solutions that address unmet health needs. The company was founded by Zhi Yang and Ya Chao Zhao has been the CEO of the company since 2007.

BioVeda Capital Singapore (Pte) Ltd. (BioVeda Capital) is a venture capital firm founded in 2000 by Lim Chin Hwee Damien. The firm is headquartered in Singapore.

Leisure Ventures Pte Ltd. operates as a holding company with interest in hotels. The company is headquartered in Singapore.

Part of Leisure Ventures Pte Ltd., LV Hotel Investment (West) Pte Ltd. owns and operates hotels. The company is based in Singapore, Singapore.

Mach7 Technologies Pte Ltd. provides enterprise image management systems and services that allow healthcare enterprises to identify, connect, and share diagnostic image and patient care intelligence. The company was founded by Rudy Sugiarto on January 4, 2009 and is headquartered in Singapore.

MSC Hotel Investments Coöperatie U.A. provides investment services. The company is headquartered in Amsterdam, the Netherlands.

Part of Leisure Ventures Pte Ltd., Presto Television Pte Ltd. provides investment services. The company is based in Singapore, Singapore.

Part of Leisure Ventures Pte Ltd., Promus Pvt Ltd. is a Maldivan company that owns and operates hotels. The company is based in Male, Maldives.

Yamu provides dinning and food services online. The company was founded by Indi Samarajiva and is headquartered in Colombo, Sri Lanka.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Nexchem Pharmaceutical Co., Ltd. produces active pharmaceutical ingredients for global markets. Its products encompass azithromycin dihydrate, clarithromycin, roxithromycin, meropenem, fenofibrate, benserazide hydrochloride, and levosulpiride. The company was founded in December 2002 and is headquartered in Jinhua, China.

MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China.

CARsgen Therapeutics Co., Ltd. develops an immunotherapy cancer treatment. It develops a novel cell-based immunotherapy using T-cells carrying chimeric antigen receptor technology for cancer treatment. The company was founded by ZongHai Li in 2014 and is headquartered in Shanghai, China.

Shanghai Drug Farm Biological Technology Co., Ltd. is a Chinese private biotechnology company that focuses on developing innovative treatments for hepatitis B, heart and kidney diseases, and ROSAH syndrome. The company utilizes breakthrough technologies in genetics and AI to discover new treatments through its unique IDinVivo platform. This platform allows the direct assessment of gene targets in living animals with intact immune systems, which has led to the identification of novel innate immunity pathways and targets. Drug Farm is now advancing multiple first-in-class drug candidates into clinical development.

Yifang Technology Group Beijing Co, Ltd. (Yifang Ventures) is a venture capital firm located in China. The firm was founded in 2007 by Eric Xu. It is headquartered in Beijing, China.

University of Houston System offers higher education degrees and job training or vocational study programs. It offers about 280 undergraduate and graduate degree programs in fields such as business, education, humanities and law. It was founded in 1927 and is headquartered in Houston, TX.

ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.

Singapore Advanced Biologics Pte Ltd. engages in the design, synthesis and validation of biologics or medicinal products. Its products and services includes siRNA and miRNA, transfection, siRNA libraries, RNA oligos, gel markers, antibody services, antibodies, peptides and. The company was founded by Mariano Garcia-Blanco and Subhash Vasudevan in 2010 and is headquartered in Singapore.

BioMers Pte Ltd. provides medical devices. It specializes in the development of novel polymer composite technology for biomedical applications. The firm offers orthodontics the total aesthetic solution: wires, brackets and retainers. The company was founded by George Aliphtiras and Mervin Fathianathan in 2005 and is headquartered in Midview City, Singapore.

Mach7 Technologies, Inc. provides cloud based enterprise clinical image management solutions to the healthcare industry. It solutions include improve specialty workflow, archive and communicate, manage data, access and share and services. The company was founded in 2007 and is headquartered in South Burlington, VT.

Asia Pacific Healthcare Advisors LLP (Asia Pacific Healthcare) is a Private Equity firm founded by Anand C. Burman and Ajay Kumar Vij in 2011. The firm has headquarters in New Delhi, India.

Part of Cuscaden Partners Pte Ltd., 68 Holdings Pte Ltd. operates as an investment holding Singaporean company. The company is based in Singapore, Singapore.

BioVeda Fund Pte Ltd invests in healthcare companies located in Singapore with strong management team, proprietary technologies, significant competitive advantages and strong market position or clear market opportunity. The fund provides financing for early stage and developmental/expansion stage capital requirements. It invests in public companies as well as private companies at mezzanine stage financings.